Homepage | CIDRAP
WEBThe Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
Infectious Disease Topics A-Z - CIDRAP
WEBA comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
COVID-19 - CIDRAP
WEBNew report: COVID more severe, longer-lasting than other respiratory diseases. COVID-19 participants most often reported fatigue, muscle aches, headache, and loss of taste and/or smell, consistent with the more extensive systemic COVID-19 effects. Mary Van Beusekom.
Osterholm Update - CIDRAP
WEBSep 5, 2024 · May 30, 2024. In "An Unfolding Saga," Dr. Osterholm and Chris Dall discuss the latest H5N1, COVID-19, and measles news. Dr. Osterholm also answers an ID query on influenza and shares the latest "This Week in Public Health History" segment. Study confirms infection in mice fed H5N1-contaminated raw milk (CIDRAP News)
About CIDRAP | CIDRAP
WEBThe Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to prevent illness and death from targeted infectious ...
Tuberculosis - CIDRAP
WEBStudy highlights impact of COVID lockdowns on drug-resistant TB diagnosis. Researchers found a 43% drop in DR-TB case notifications in a South African province after COVID-19 lockdowns were implemented. Chris Dall.
CIDRAP in the News
WEBAug 15, 2024 In Foreign Affairs, Director Michael Osterholm, PhD, MPH, and coauthor Mark Olshaker discuss how governments and international organizations have done far too little to prepare for the next pandemic-causing virus.. Jul 2, 2024 CIDRAP releases two new Research and Development Roadmaps: one for developing tools to combat Nipah virus and the other for tools to combat Lassa fever.
SARS - CIDRAP
WEBNov 10, 2021 · In the first known estimate of the SARS-CoV spillover risk from bats to people, researchers who studied bat populations in South East Asia and interactions with humans estimate that about 66,280 people a year are infected each year. The team, based at EcoHealth Alliance, published their findings today in Nature Communications.
COVID-19: CIDRAP Commentaries
WEBCOVID-19: The CIDRAP Viewpoint. Starting at the beginning of the pandemic, CIDRAP compiled a groundbreaking of series of reports on key aspects of COVID-19, such as what direction the pandemic might take, how to communicate risks effectively, smart testing for the virus and for antibodies to it, contact tracing, surveillance, ensuring a ...
COVID-19: The CIDRAP Viewpoint
WEBApr 30, 2020 · Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza. Kristine A. Moore, MD, MPH; Marc Lipsitch, DPhil; John M. Barry, MA; Michael T ...